Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 0.67x is 47% below its estimated 1-year average of 1.27x, near the low end of its estimated 1-year range (0.67x–1.61x).
As of 2026-10-06T15:41:16.854Z.
Calculation as of: 2026-10-06T15:41:16.854Z.
Quote observation: 2026-10-06T15:40:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 95041c5b42fb2606cad9ef3462ba84fd1ad3ee370422abc55eb90f4681bfa3ac
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
0.67x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 447 covered companies
CURRENT VS SECTOR MEDIAN
-84.05%
vs the sector median at left
Market Cap
$549273.00
EV/Sales Ratio
0.95x
TTM Avg
22.73x
3Y Avg
233.34x
5Y Avg
409.95x
Market Cap
$832324.00
EV/Sales Ratio
N/A
TTM Avg
2170.65x
3Y Avg
2189.01x
5Y Avg
2189.01x
Market Cap
$873508.00
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$853809.00
EV/Sales Ratio
N/A
TTM Avg
78.84x
3Y Avg
47.25x
5Y Avg
902.93x
Market Cap
$873967.00
EV/Sales Ratio
N/A
TTM Avg
48327.79x
3Y Avg
43699.06x
5Y Avg
43699.06x
Market Cap
$1.04M
EV/Sales Ratio
N/A
TTM Avg
26520.58x
3Y Avg
26520.58x
5Y Avg
26520.58x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CDT Equity Inc. (CDT) | $678164.00 | 0.67x | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $549273.00 | 0.95x | 22.73x | 233.34x | 409.95x |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $832324.00 | N/A | 2170.65x | 2189.01x | 2189.01x |
| Bone Biologics Corporation (BBLG)vs › | $873508.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $853809.00 | N/A | 78.84x | 47.25x | 902.93x |
| GlucoTrack, Inc. (GCTK)vs › | $873967.00 | N/A | 48327.79x | 43699.06x | 43699.06x |
| Niki BioSolutions, Inc. (NIKI)vs › | $374618.00 | N/A | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | N/A | 26520.58x | 26520.58x | 26520.58x |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 0.67x |
| 2026-10-02 | 0.67x |
| 2026-10-01 | 0.67x |
| 2026-09-30 | 0.67x |
| 2026-09-29 | 0.67x |
| 2026-09-28 | 0.67x |
| 2026-09-25 | 0.67x |
| 2026-09-24 | 0.67x |
| 2026-09-23 | 0.67x |
| 2026-09-22 | 0.67x |
| 2026-09-21 | 0.67x |
| 2026-09-18 | 0.67x |
| 2026-09-17 | 0.67x |
| 2026-09-16 | 0.67x |
| 2026-09-15 | 0.67x |
| 2026-09-14 | 0.67x |
| 2026-09-11 | 0.67x |
| 2026-09-10 | 0.67x |
| 2026-09-09 | 0.68x |
| 2026-09-08 | 0.68x |
| 2026-09-04 | 0.68x |
| 2026-09-03 | 0.68x |
| 2026-09-02 | 0.68x |
| 2026-09-01 | 0.68x |
| 2026-08-31 | 0.69x |
| 2026-08-28 | 0.69x |
| 2026-08-27 | 0.69x |
| 2026-08-26 | 0.69x |
| 2026-08-25 | 0.69x |
| 2026-08-24 | 0.69x |
| 2026-08-21 | 0.70x |
| 2026-08-20 | 0.70x |
| 2026-08-19 | 0.70x |
| 2026-08-18 | 0.70x |
| 2026-08-17 | 0.70x |
| 2026-08-14 | 0.70x |
| 2026-08-13 | 0.70x |
| 2026-08-12 | 1.56x |
| 2026-08-11 | 1.56x |
| 2026-08-10 | 1.56x |
| 2026-08-07 | 1.56x |
| 2026-08-06 | 1.56x |
| 2026-08-05 | 1.56x |
| 2026-08-04 | 1.56x |
| 2026-08-03 | 1.56x |
| 2026-07-31 | 1.56x |
| 2026-07-30 | 1.56x |
| 2026-07-29 | 1.55x |
| 2026-07-28 | 1.56x |
| 2026-07-27 | 1.56x |
| 2026-07-24 | 1.56x |
| 2026-07-23 | 1.56x |
| 2026-07-22 | 1.56x |
| 2026-07-21 | 1.56x |
| 2026-07-20 | 1.56x |
| 2026-07-17 | 1.56x |
| 2026-07-16 | 1.56x |
| 2026-07-15 | 1.56x |
| 2026-07-14 | 1.56x |
| 2026-07-13 | 1.56x |
| 2026-07-10 | 1.56x |
| 2026-07-09 | 1.56x |
| 2026-07-08 | 1.56x |
| 2026-07-07 | 1.56x |
| 2026-07-06 | 1.56x |
| 2026-07-02 | 1.56x |
| 2026-07-01 | 1.56x |
| 2026-06-30 | 1.56x |
| 2026-06-29 | 1.56x |
| 2026-06-26 | 1.56x |
| 2026-06-25 | 1.57x |
| 2026-06-24 | 1.58x |
| 2026-06-23 | 1.58x |
| 2026-06-22 | 1.59x |
| 2026-06-18 | 1.57x |
| 2026-06-17 | 1.57x |
| 2026-06-16 | 1.57x |
| 2026-06-15 | 1.57x |
| 2026-06-12 | 1.57x |
| 2026-06-11 | 1.57x |
| 2026-06-10 | 1.57x |
| 2026-06-09 | 1.57x |
| 2026-06-08 | 1.57x |
| 2026-06-05 | 1.57x |
| 2026-06-04 | 1.57x |
| 2026-06-03 | 1.57x |
| 2026-06-02 | 1.57x |
| 2026-06-01 | 1.57x |
| 2026-05-29 | 1.58x |
| 2026-05-28 | 1.57x |
| 2026-05-27 | 1.58x |
| 2026-05-26 | 1.57x |
| 2026-05-22 | 1.58x |
| 2026-05-21 | 1.58x |
| 2026-05-20 | 1.58x |
| 2026-05-19 | 1.58x |
| 2026-05-18 | 1.59x |
| 2026-05-15 | 1.59x |
| 2026-05-14 | 1.60x |
| 2026-05-13 | 1.60x |
| 2026-05-12 | 1.60x |
| 2026-05-11 | 1.60x |
| 2026-05-08 | 1.60x |
| 2026-05-07 | 1.60x |
| 2026-05-06 | 1.61x |
| 2026-05-05 | 1.60x |
| 2026-05-04 | 1.60x |
| 2026-05-01 | 1.61x |
